First human trial of ReNeuron's neural stem cell product in stroke
This article was originally published in Scrip
Executive Summary
ReNeuron's expanded neural stem cell product, ReN001, is to be evaluated in patients disabled by ischaemic stroke. A UK clinical study in 12 patients is expected to start in the second quarter of this year, with principal investigator Dr Keith Muir saying the ultimate aim is to repair brain tissue.